Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells

COX-2 can be considered as a clinically relevant molecular target for adjuvant, in particular radiosensitizing treatments. In this regard, using selective COX-2 inhibitors, e.g., in combination with radiotherapy or endoradiotherapy, represents an interesting treatment option. Based on our own findin...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandt, Florian, Ullrich, Martin, Seifert, Verena, Haase-Kohn, Cathleen, Richter, Susan, Kniess, Torsten, Pietzsch, Jens, Laube, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573605/
https://www.ncbi.nlm.nih.gov/pubmed/36235124
http://dx.doi.org/10.3390/molecules27196587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573605/
https://www.ncbi.nlm.nih.gov/pubmed/36235124
http://dx.doi.org/10.3390/molecules27196587

Ejemplares similares